Support more aggressive prescription drug price negotiations, caps on out-of-pocket costs, and improved price transparency.

Johnny O supports more aggressive price negotiations, capping out-of-pocket costs and improving price transparency so patients face fewer surprise bills.

A commitment to stronger Medicare drug pricing protections.

Johnny O – Democrat for Congress | Johnny’s Priorities
campaign · campaign_site · model gpt-5.4-mini

"expand access to prescription price caps."

Olszewski's affordability agenda commits to expanding access to prescription price caps.

Olszewski Unveils Affordability Agenda to Address the Cost of Living Crisis
secondary · other · model gpt-5.4-mini

Its official title states it would expand the drug price negotiation program under title XI of the Social Security Act, apply prescription drug inflation rebates under Medicare to drugs furnished in the commercial market, and establish out-of-pocket limits on expenditures for prescription drugs under private health insurance.

H.R.6166 proposes expanding Medicare drug price negotiation, extending inflation rebate rules to the commercial market, and setting prescription drug out-of-pocket limits for private insurance.

All Information (Except Text) for H.R.6166 - Lowering Drug Costs for American Families Act | Congress.gov | Library of Congress
secondary · other · model gpt-5.5

H.R.6166 was introduced in the House on 11/20/2025. Its official title states it would expand the drug price negotiation program under title XI of the Social Security Act, apply prescription drug inflation rebates under Medicare to drugs furnished in the commercial market, and establish out-of-pocket limits on expenditures for prescription drugs under private health insurance. The bill status remains Introduced.

Olszewski-aligned drug-pricing goals were advanced through an introduced bill, but it has not progressed beyond introduction, so the commitment is not delivered.

partial same_term A for effort

All Information (Except Text) for H.R.6166 - Lowering Drug Costs for American Families Act | Congress.gov | Library of Congress
secondary · model gpt-5.4-mini · confidence 92%

H.R.6166 sponsor: Rep. Pallone, introduced 11/20/2025. Latest action: referred to House Energy and Commerce, Ways and Means, and Education and Workforce. Tracker status: Introduced; steps to law still show Passed House, Passed Senate, To President, Became Law not completed.

The principal promise-aligned federal bill was only introduced and referred to committees; it had not passed the House, Senate, or become law, so the promised federal policy was not delivered in Olszewski's term.

never same_term

All Information (Except Text) for H.R.6166 - Lowering Drug Costs for American Families Act | Congress.gov | Library of Congress
secondary · model gpt-5.5 · confidence 95%

H.R.6166 states that it would expand the drug price negotiation program, apply prescription drug inflation rebates to drugs in the commercial market, and establish out-of-pocket limits for prescription drugs under private health insurance.

The bill text closely matches the promise on more aggressive drug negotiation and out-of-pocket caps, but it is proposed legislation rather than enacted law.

never same_term

Text for H.R.6166 - Lowering Drug Costs for American Families Act | Congress.gov | Library of Congress
secondary · model gpt-5.5 · confidence 94%

Congress.gov lists 46 current cosponsors for H.R.6166, with Maryland [1]. The Maryland cosponsor shown in the list is Rep. Steny H. Hoyer, dated 12/01/2025; Johnny Olszewski is not shown in the cosponsor list.

The official cosponsor page does not support the prior claim that Olszewski cosponsored H.R.6166; without a listed sponsorship or cosponsorship, this source does not show a concrete Olszewski action on that bill.

never same_term

Cosponsors for H.R.6166 - Lowering Drug Costs for American Families Act | Congress.gov | Library of Congress
secondary · model gpt-5.5 · confidence 90%

Section 71203 of H.R.1 is titled 'Expanding and clarifying the exclusion for orphan drugs under the Drug Price Negotiation Program' and amends the Social Security Act's drug price negotiation provisions.

A law enacted during Olszewski's term changed the Medicare drug negotiation program by expanding an exclusion, which cuts against the promise of more aggressive negotiations rather than delivering it.

never same_term

Text for H.R.1 - 119th Congress | Congress.gov | Library of Congress
secondary · model gpt-5.5 · confidence 86%

Roll Call 190 on H.R.1, the One Big Beautiful Bill Act, passed 218-214 on July 3, 2025. The Clerk lists Olszewski, Democratic, Maryland, vote: No.

Olszewski voted against the enacted H.R.1 package that included a drug-negotiation exclusion expansion. This is a concrete opposing vote, but the bill passed and the promised drug-pricing policy was not delivered.

never same_term A for effort

Roll Call 190 | Bill Number: H.R.1 | Office of the Clerk, U.S. House of Representatives
secondary · model gpt-5.5 · confidence 84%